Jacksonville, FL, August 20, 2016 --(PR.com
)-- Dean of the Tufts Friedman School of Nutrition Science and Policy, Dariush Mozaffarian, MD, DrPH, will be the keynote speaker at the American Society for Preventive Cardiology (ASPC) 2016 Congress on Atherosclerotic Cardiovascular Disease (ASCVD) Prevention in Boca Raton, Fla. on Saturday, September 17. Dr. Mozaffarian is a cardiologist and Jean Mayer Chair in Nutrition at the Tufts Friedman School of Nutrition Science and Policy. He is a thought leader on the science of lifestyle and congenital heart disease, and he strives to create system interventions and policies to effectively reduce the burdens of these issues. His keynote presentation will address rethinking dietary fat.
Imaging techniques to assess risk, such as carotid intima media thickness and coronary artery calcium scoring have attracted considerable interest as adjuncts for cardiovascular risk stratification. On Sunday, September 18, Amit Khera, MD, FASPC, Medical Director of Cardiac Rehabilitation and Associate Professor of Medicine at the University of Texas Southwestern Medical School in Dallas and Parkland Memorial Hospital, will discuss lessons that have been learned from MESA and beyond, and how non-invasive imaging methods can help guide therapy.
The closing presentation on Sunday, September 18, will be given by Seth Baum, MD, FASPC, who is the Medical Director of Women’s Preventive Cardiology at Boca Raton Regional Hospital and president-elect of ASPC. During his presentation, Dr. Baum will discuss new lipid altering medications that have recently become available. Positive results in several ASCVD clinical trials have lit up the overall evolution of the management of ASCVD and are being translated into new therapeutic strategies for clinical practice.
The Congress will also feature a town hall forum entitled “Unraveling a Therapeutic Conundrum: A Town Hall on Barriers to Access PCSK9 Inhibitors.” This event will bring together representatives of ASPC, the American Association of Clinical Endocrinologists, the American College of Cardiology, the FH Foundation, and the National Lipid Association to address consumers’ limited access to PCSK9 inhibitors, a new drug that can dramatically reduce the amount of harmful LDL cholesterol circulating in the bloodstream. These thought-leaders will unite to discuss this issue and raise awareness in hopes of changing policies to allow more widespread access to PCSK9 inhibitors.
In addition to a great line-up of world renowned speakers, attendees will have the chance to connect with the faculty and other thought leaders in the field of preventive cardiology at the oceanfront Boca Raton Resort and Club. The discounted ASPC meeting room rates end on August 19. Attendees are encouraged to make their hotel reservations soon. During the conference, practitioners will gain real-world perspective on how to translate current atherosclerotic cardiovascular disease prevention research into effective treatment strategies for clinical practice.
The American Society for Preventive Cardiology is a national organization of healthcare providers and researchers dedicated to the prevention of atherosclerotic cardiovascular disease. The mission of the ASPC is to promote the prevention of atherosclerotic cardiovascular disease, advocate for the prevention of cardiovascular health, and disseminate high-quality, evidence-based information through education of clinicians.